J.T. Thigpen

12.6k total citations · 4 hit papers
175 papers, 8.5k citations indexed

About

J.T. Thigpen is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, J.T. Thigpen has authored 175 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Reproductive Medicine, 78 papers in Obstetrics and Gynecology and 51 papers in Surgery. Recurrent topics in J.T. Thigpen's work include Ovarian cancer diagnosis and treatment (86 papers), Endometrial and Cervical Cancer Treatments (72 papers) and Intraperitoneal and Appendiceal Malignancies (29 papers). J.T. Thigpen is often cited by papers focused on Ovarian cancer diagnosis and treatment (86 papers), Endometrial and Cervical Cancer Treatments (72 papers) and Intraperitoneal and Appendiceal Malignancies (29 papers). J.T. Thigpen collaborates with scholars based in United States, Australia and United Kingdom. J.T. Thigpen's co-authors include Brian N. Bundy, Peter G. Rose, E. Blake Watkins, Daniel L. Clarke‐Pearson, Mitchell Maiman, John A. Blessing, Howard D. Homesley, W.J. Hoskins, George Omura and Marcus E. Randall and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

J.T. Thigpen

159 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

1999 2.0k citations Peter G. Rose, Brian N. Bundy et al. New England Journal of Medicine profile →
Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

2005 625 citations Marcus E. Randall, Virginia L. Filiaci et al. Journal of Clinical Oncology profile →
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study

1992 400 citations W.J. Hoskins, Brian N. Bundy et al. Gynecologic Oncology profile →
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

2008 378 citations Martee L. Hensley, J.T. Thigpen et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by J.T. Thigpen

Since Specialization

Citations

This map shows the geographic impact of J.T. Thigpen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.T. Thigpen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.T. Thigpen more than expected).

Fields of papers citing papers by J.T. Thigpen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.T. Thigpen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.T. Thigpen. The network helps show where J.T. Thigpen may publish in the future.

Co-authorship network of co-authors of J.T. Thigpen

This figure shows the co-authorship network connecting the top 25 collaborators of J.T. Thigpen. A scholar is included among the top collaborators of J.T. Thigpen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.T. Thigpen. J.T. Thigpen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors Associated With Deciding Between Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening Among High-Risk Women Enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group Study 2017 ·Obstetrical & Gynecological Survey ·(unknown), Marion Piedmonte, Paul K. J. Han, Richard P. Moser, Joan L. Walker, Gustavo C. Rodriguez, John F. Boggess, Thomas Rutherford, Oliver Zivanovic, David E. Cohn, J.T. Thigpen, Robert M. Wenham, Michael Friedländer, Chad A. Hamilton, Jamie N. Bakkum‐Gamez, Alexander Olawaiye, Martee L. Hensley, Mark H. Greene, Helen Huang, Lari Wenzel	1
2	Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis 2016 ·Gynecologic Oncology ·Kathleen N. Moore, James Java, (unknown), Peter G. Rose, Rachelle Lanciano, Paul DiSilvestro, J.T. Thigpen, Yi-Chun Lee, Krishnansu S. Tewari, Junzo Chino, Shelly Seward, David S. Miller, Ritu Salani, David H. Moore, Frederick B. Stehman	31
3	Photometric calibration for quantitative spectral microscopy under transmitted illumination 2010 ·Journal of Microscopy ·J.T. Thigpen, Fatima A. Merchant, Shishir K. Shah	5
4	Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study 2009 ·Gynecologic Oncology ·Gini F. Fleming, Michael W. Sill, Kathleen M. Darcy, D. Scott McMeekin, J.T. Thigpen, Lisa Adler, Jonathan S. Berek, Julia Chapman, Paul DiSilvestro, Ira Horowitz, James V. Fiorica	200
5	The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: A Gynecologic Oncology Group study 2007 ·Gynecologic Oncology ·D. Scott McMeekin, Virginia L. Filiaci, J.T. Thigpen, Holly H. Gallion, Gini F. Fleming, William H. Rodgers	110
6	Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma 2006 ·Cancer ·G. Larry Maxwell, Chunqiao Tian, John I. Risinger, Carol L. Brown, G. Scott Rose, J.T. Thigpen, Gini F. Fleming, Holly H. Gallion, Wendy R. Brewster	80
7	Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study breakdown → 2005 ·Journal of Clinical Oncology ·Marcus E. Randall, Virginia L. Filiaci, Hyman B. Muss, Nick M. Spirtos, Robert S. Mannel, Jeffrey Fowler, J.T. Thigpen, J Bénda	625
8	Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group 2003 ·Journal of Clinical Oncology ·Marcus E. Randall, (unknown), H. B. Muss, (unknown), (unknown), (unknown), J.T. Thigpen, J Bénda	51
9	Reliability assessment of soluble c-erb B-2 concentrations in the saliva of healthy women and men 2001 ·Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology ·Charles F. Streckfus, Lenora Bigler, Tracy M. Dellinger, (unknown), (unknown), (unknown), Albert Kingman, J.T. Thigpen	25
10	A Preliminary Study of CA15-3, c-erbB-2, Epidermal Growth Factor Receptor, Cathepsin-D, and p53 in Saliva Among Women with Breast Carcinoma 2000 ·Cancer Investigation ·Charles F. Streckfus, Lenora Bigler, Michelle Tucci, J.T. Thigpen	130
11	Chemotherapy for ovarian cancer: Current concepts 1999 ·Seminars in Surgical Oncology ·(unknown), J.T. Thigpen	22
12	CA 15-3 and c- erb B-2 presence in the saliva of women 1999 ·Clinical Oral Investigations ·Charles F. Streckfus, Lenora Bigler, Tracy M. Dellinger, (unknown), (unknown), J.T. Thigpen	32
13	Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer breakdown → 1999 ·New England Journal of Medicine ·Peter G. Rose, Brian N. Bundy, E. Blake Watkins, J.T. Thigpen, (unknown), Mitchell Maiman, Daniel L. Clarke‐Pearson, (unknown)	2049
14	Salivary slgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study 1998 ·Special Care in Dentistry ·(unknown), Lenora Bigler, Michelle Tucci, (unknown), (unknown), J.T. Thigpen, Charles F. Streckfus, (unknown)	46
15	A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study. 1994 ·Journal of Clinical Oncology ·J.T. Thigpen, John A. Blessing, Philip J. DiSaia, Edgardo Yordan, Linda F. Carson, Christina Evers	128
16	Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. 1991 ·Journal of Clinical Oncology ·J.T. Thigpen, John A. Blessing, Jackson B. Beecham, Howard D. Homesley, Edgardo Yordan	119
17	Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study 1990 ·Gynecologic Oncology ·C. Paul Morrow, Brian N. Bundy, Howard D. Homesley, William T. Creasman, Ned B. Hornback, Robert J. Kurman, J.T. Thigpen	114
18	The Year book of oncology 1989 ·Bulletin of Miscellaneous Information (Royal Gardens Kew) ·Robert C. Young, Joseph V. Simone, Robert F. Ozols, Patrick J. Loehrer, J.T. Thigpen, R.J. Arceci	1
19	Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (A Gynecologic Oncology Group study) 1989 ·Gynecologic Oncology ·Edward B. Weiser, Brian N. Bundy, W.J. Hoskins, Paul B. Heller, (unknown), Philip J. DiSaia, Stephen Curry, John B. Schlaerth, J.T. Thigpen	84
20	A Phase II Trial of Vinblastine in Patients with Advanced or Recurrent Endometrial Carcinoma A Southwest Oncology Group Study 1987 ·American Journal of Clinical Oncology ·J.T. Thigpen, (unknown), (unknown), Harry E. Hynes, William A. Nahhas, Robert J. Belt, Stanley P. Balcerzak, Robert B. Epstein, John J. Costanzi	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact